SPY422.11-2.37 -0.56%
DIA340.76-2.65 -0.77%
IXIC14,039.68-33.17 -0.24%

BRIEF-Medicenna Announces Peer-Reviewed Publication Of Clinical Data From Phase 2B Trial Evaluating MDNA55

05/07/2021 09:07
BRIEF-Medicenna Announces Peer-Reviewed Publication Of Clinical Data From Phase 2B Trial Evaluating MDNA55

- Medicenna Therapeutics Corp MDNA.TO:

  • MEDICENNA ANNOUNCES THE PEER-REVIEWED PUBLICATION OF CLINICAL DATA FROM PHASE 2B TRIAL EVALUATING MDNA55 IN RECURRENT GLIOBLASTOMA

Source text for Eikon: ID:nGNX1DGMNX

Further company coverage: MDNA.TO


(([email protected];))